Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (388)
- Scheduling (national classification system) (171)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
770 result(s) found, displaying 151 to 175
-
Corporate reportsMedical Devices Safety Update (MDSU) provides practical advice and information about medical device safety.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsThe strategy outlines the approach we will use to identify, engage with, and educate stakeholders about regulatory requirements and our compliance outcomes.
-
Meeting statementsCommunique from the 4th meeting of the Women's Health Products Working Group (WHPWG), 31 July 2023.
-
Scheduling decisions (final)Read the notice of final decisions to not amend the Poisons Standard in relation to ketamine, esketamine and methysergide
-
Meeting statementsFind out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2024
-
Scheduling decisions (final)Read the notice of final decisions to not amend the Poisons Standard in relation to comfrey.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meeting, held in June 2023
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 2 November 2023
-
Meeting statementsCommunique from the meeting of the TGACC
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2022-23
-
Scheduling decisions (final)Notification of amendments to the Poisons Standard in relation to final decision in relation to lead, joint ACMS-ACCS #34
-
Corporate reportsAccess our report on medical devices manufactured at the point-of-care - analysis of survey results by sector.
-
Meeting statementsRead the meeting summary for the National Symposium on Point-of-care Manufacturing of medical devices, held on 19 June 2023.
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the current Poisons Standard - ACMS #41, ACCS #36, Joint ACMS-ACCS #33
-
Scheduling submissionsFind out about public submissions on interim decisions for scheduling matters referred to Advisory Committees meetings, held in March 2023
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (final)Stay updated on final decisions for substances referred to the March 2023 ACMS/ACCS meetings.
-
Corporate reportsRead our business plan 2023-24 to find out about our strategic priorities and activities.
-
Meeting statementsRead the meeting statement from 10 August 2023 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement